Streptomycetaceae: NCBI 2062, [family]

Back to details

| Actinoplanaceae| Actinoplanaceae Couch 1955| Streptomycetaceae| Streptomycetaceae Waksman and Henrici 1943 (Approved Lists 1980) emend. Huang et al. 2017| Streptomycetaceae Waksman and Henrici 1943 (Approved Lists 1980) emend. Kim et al. 2003| Streptomycetaceae Waksman and Henrici 1943 (Approved Lists 1980) emend. Nouioui et al. 2018| Streptomycetaceae Waksman and Henrici 1943 (Approved Lists 1980) emend. Rainey et al. 1997| Streptomycetaceae Waksman and Henrici 1943 (Approved Lists 1980) emend. Zhi et al. 2009

1. Production of antibiotics: Streptomyces species are prolific producers of antibiotics, many of which have been used clinically to treat bacterial infections in humans. Examples include streptomycin, tetracycline, erythromycin, and vancomycin. These antibiotics have played a crucial role in the treatment of various bacterial diseases, including tuberculosis, pneumonia, and skin infections.

2. Antibiotic resistance: While Streptomyces species produce antibiotics that are effective against many bacterial pathogens, some bacteria have developed resistance to these antibiotics. Antibiotic resistance is a growing global health concern and poses challenges for the treatment of bacterial infections. Streptomyces bacteria themselves can harbor antibiotic resistance genes, and their interactions with other bacteria in the environment may contribute to the spread of antibiotic resistance.

3. Potential for drug discovery: Streptomyces bacteria continue to be a rich source of bioactive compounds with potential pharmaceutical applications. Scientists study Streptomyces strains to identify novel antibiotics and other bioactive molecules that could be developed into new drugs for the treatment of infectious diseases, cancer, and other health conditions.

4. Environmental interactions: While Streptomyces bacteria are primarily soil-dwelling microorganisms, they can also be found in various other environments, including water, plants, and animals. Streptomyces species interact with other microorganisms and their hosts in complex ways, influencing ecosystem dynamics and potentially impacting human health indirectly through their effects on environmental microbiota and ecosystems.

5. Rare infections: Although Streptomyces species are not typically considered human pathogens, there have been rare reports of infections caused by these bacteria, particularly in immunocompromised individuals or those with underlying health conditions. These infections are often associated with traumatic injuries, surgical wounds, or exposure to contaminated environments.

Other Sources for more information:

• Immune Epitope Database
• The NCBI taxonomy database
• UniProt
• Immune Epitope Taxonomy Database (IEDB)
• AI Engines For more Details: Perplexity  Kagi Labs  You 

Legend

• The interactions are based on data from 1000 healthy individuals using shotgun 10M reads Precision Biome, a provider in full conformity to EU regulations for health information
• The width of the lines indicates R² (the coefficient of determination)
• Green indicates positive slope
• Red indicates negative
• Interactions are not two way because incidence of each bacteria are different

Streptomycetaceae impacts on other bacteria of the same rank

R2	Slope	Tax Name	Parent Chart
0.28843945264816284	0.6419145464897156	Bruguierivoracaceae	Parent Taxa
0.28210678696632385	0.652737021446228	Nectriaceae	Parent Taxa
0.2627250850200653	0.5654692053794861	Gemmatimonadaceae	Parent Taxa

Other bacteria of the same rank impacting Streptomycetaceae

R2	Slope	Tax Name	Parent Chart
0.31450602412223816	0.7060483694076538	Paenibacillaceae	Parent Taxa